Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|December 6, 2022
Safety and efficacy of endovascular thrombolysis in patients with acute cerebral venous sinus thrombosis: A systematic reviewSepideh Paybast, Reza Mohamadian, Ali Emami, et al.
Multiple Sclerosis and Related Disorders|December 12, 2025
Hypogammaglobulinemia and infection risks in multiple sclerosis patients receiving anti-CD20 monoclonal antibodies: Incidence, clinical implications, and longitudinal insights from a three-year Iranian cohortElham Asl Fallah, Ali Emami, Nahid Beladi Moghaddam, et al.
Current Journal of Neurology|October 21, 2024
New diagnosis of multiple sclerosis in the setting of recent Sinopharm COVID-19 vaccine (BBIBP-CorV) exposure: A series of clinical cases and updated review of the literatureSepideh Paybast, Melika Jameie, Mojtaba Shahbazi, et al.
Multiple Sclerosis and Related Disorders|July 6, 2023
Investigation of the safety of live attenuated varicella-zoster virus vaccination in patients with relapse-remitting multiple sclerosis treated with natalizumab: A case series and review of the literatureSepideh Paybast, Mohammad Ali Sahraian, Mohammad Ali Nahayati, et al.
Clinical Nutrition ESPEN|November 13, 2020
The correlation of serum adiponectin and insulin resistance with the presence and severity of dementia in non-obese Alzheimer's patientsSeyed Amir Hejazi, Kambiz Rohampour, Ehsan Sharifipour, et al.
Multiple Sclerosis and Related Disorders|February 19, 2025
Is it time to consider the live attenuated varicella-zoster virus (VZV) vaccination safe in patients with multiple sclerosis treated with natalizumab? An extension study of the first Iranian experienceSepideh Paybast, Mohammad Ali Nahayati, Sareh Shahmohammadi, et al.
The Neurologist|March 18, 2022
Therapeutic Plasma Exchange (TPE) Complications in Patients With Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS): A Report From a Tertiary CenterShirin Mavandadi, Mehran Moghaddami, Ali P Meysami, et al.
Multiple Sclerosis and Related Disorders|February 1, 2026
Extended interval dosing of off-label rituximab in multiple sclerosis: A real-world retrospective analysis of clinical efficacy and safetySepideh Paybast, Melika Jameie, Zohreh Tajabadi, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 27, 2025
Dermatologic findings after initiation of fingolimod in patients with multiple sclerosis: A real-world experience of five-year follow-upMonireh Samimi, Aida Sajedi, Sepideh Paybast, et al.
Multiple Sclerosis and Related Disorders|February 5, 2025
Investigating treatment alternatives for fingolimod in patients with multiple sclerosis developed refractory fingolimod-related genital Human Papilloma Virus (HPV) infectionSepideh Paybast, Fereshteh Ashtari, Nahid Beladi Moghaddam, et al.
Pageof 4